Andrey Popatanasov | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Andrey Popatanasov | Neuroscience | Best Researcher Award 

Research Assistant, at Institute of Neurobiology, Bulgarian Academy of Sciences, Bulgaria.

Andrey Popatanasov is a dedicated Research Assistant at the Institute of Neurobiology, Bulgarian Academy of Sciences (BAS). His academic journey is distinguished by a multidisciplinary approach: he holds Bachelor’s degrees in Psychology, Physics, and Biology, complemented by Master’s degrees in Clinical Psychology, Medical Physics, and Molecular Biology. Currently, he is pursuing a PhD in Human and Animal Physiology, expected to be conferred this year. Professionally, Popatanasov has been affiliated with various institutes under BAS, contributing to integrative research that bridges the gap between basic science and its application to human well-being. His work aims to advance our understanding of neurobiological mechanisms and their implications for human health.

Professional Profile

Scopus

ORCID

Education

Popatanasov’s educational foundation is both broad and deep, reflecting his commitment to understanding complex biological systems. He earned Bachelor’s degrees in Psychology, Physics, and Biology, providing him with a diverse scientific perspective. Building on this, he completed Master’s degrees in Clinical Psychology, Medical Physics, and Molecular Biology, each aligning with his evolving research interests. Currently, he is finalizing his PhD in Human and Animal Physiology, which will further enhance his expertise in neurobiology. This extensive academic background equips him to approach research questions from multiple disciplinary angles, fostering innovative solutions to complex problems in neuroscience and related fields.

Experience

Throughout his academic and professional career, Popatanasov has gained substantial experience in research and academia. He has been involved in various research projects at institutes of the Bulgarian Academy of Sciences, where he applied his multidisciplinary training to investigate neurobiological phenomena. Currently, as a Research Assistant at the Institute of Neurobiology, he contributes to studies that explore the molecular and physiological aspects of the nervous system. His role encompasses experimental design, data analysis, and dissemination of findings, all aimed at advancing scientific knowledge and its practical applications in medicine and healthcare.

Research Interests

Popatanasov’s research interests lie at the intersection of neuroscience, psychology, biology, and physics. He investigates the molecular mechanisms underlying cognitive, affective, and pro-social behaviors, particularly in pathological conditions. His work includes in silico and in vitro studies on ligand interactions with brain biomolecules, as well as the impact of electromagnetic radiation from quantum generators on living and non-living matter. Additionally, he explores the relationship between language complexity and brain development in children with disabilities. These interdisciplinary pursuits aim to uncover fundamental insights into brain function and inform therapeutic strategies for various neurological disorders.

Awards

While specific awards are not detailed in the provided information, Popatanasov’s contributions to neuroscience and interdisciplinary research are noteworthy. His work has been recognized through his involvement in peer-reviewed publications and editorial roles, indicating a respected standing within the scientific community. His dedication to advancing knowledge in neurobiology and related fields reflects a commitment to excellence in research and its application to human health.

Top Noted Publications

Popatanasov has co-authored several significant publications in reputable scientific journals. One notable article is “New Insights into the Cytoarchitecture of the Rat Spinal Trigeminal Nucleus,” published in the Proceedings of the Bulgarian Academy of Sciences in July 2024. This study provides detailed histological analysis of the spinal trigeminal nucleus, contributing to the understanding of sensory processing in the trigeminal system. Another key publication is “Expression of Neurotrophic Factors and Their Receptors in the Rat Spinal Trigeminal Nucleus,” also in the Proceedings of the Bulgarian Academy of Sciences, published in September 2024. This research examines the role of neurotrophic factors in neuronal differentiation and survival, with implications for pain modulation and neuroplasticity. These publications underscore Popatanasov’s active engagement in advancing neurobiological research.proceedings.bas.bg+2proceedings.bas.bg+2proceedings.bas.bg+2proceedings.bas.bg

Publications with Hyperlinks and Citation Information

🧠 1. New Insights into the Cytoarchitecture of the Rat Spinal Trigeminal Nucleus

DOI: 10.7546/CRABS.2024.07.11

This study delves into the structural organization of the spinal trigeminal nucleus (SpV), a pivotal relay station for processing sensory information from the face, head, and oral cavity. Historically considered a continuous structure, it was revealed to be subdivided into three distinct subnuclei: oral, interpolar, and caudal. Utilizing histological techniques, the researchers identified unique cytoarchitectural features characteristic of each subnucleus, providing insights into the spatial distribution and density of neuronal populations across the rostrocaudal extent of the SpV. These findings enhance the understanding of the neural circuitry underlying sensory processing in the trigeminal system and may have implications for the diagnosis and treatment of disorders involving altered trigeminal function. proceedings.bas.bg+1proceedings.bas.bg+1

🧬 2. Expression of Neurotrophic Factors and Their Receptors in the Rat Spinal Trigeminal Nucleus

DOI: 10.7546/CRABS.2024.09.15

In this follow-up study, the authors investigated the expression of neurotrophic factors—nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and glial-derived neurotrophic factor (GDNF)—and their corresponding receptors in the rat SpV. Using primary antibodies against these neurotrophic factors and their receptors, the researchers found immunoreactive cells scattered along the entire length of the nucleus in all three subnuclei. Notably, the majority of spinal trigeminal neurons were intensely immunostained for all the neurotrophic factors examined and were richly endowed with their Trk receptors. The study also observed regional variations in the expression levels of these factors and receptors within the subnuclei. Given that these neurotrophic factors are involved in mechanisms of central sensitization in trigeminal nociceptive pathways, the findings suggest that neurotrophins may contribute to a better understanding of the fundamental mechanisms of orofacial pain. proceedings.bas.bg

Conclusion

Andrey Popatanasov is a highly interdisciplinary researcher with a solid academic and professional foundation. His efforts to integrate diverse scientific domains (psychology, neuroscience, physics, biology) are commendable. He has made meaningful contributions to both theoretical and applied research, especially in brain science, cognitive behavior, and molecular biology.

Maura Massimino | Neuroscience | Best Research Article Award

Published on by Cognitive Scientist Awards

Dr. Maura Massimino | Neuroscience | Best Research Article Award

Fondazione IRCCS Istituto Nazionale dei tumori di Milano, Italy

Dr. Maura Rita Maria Massimino is a highly respected Italian pediatric oncologist and the Director of the Pediatric Oncology Unit at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan. With over three decades of clinical and academic excellence, she has dedicated her career to advancing the care of children with cancer, particularly central nervous system tumors. She is a registered medical professional in Milan and a prolific researcher, having authored over 350 peer-reviewed articles. In addition to clinical leadership, Dr. Massimino is a dedicated educator, teaching pediatric oncology at leading universities in Milan. She is widely recognized for her role in national and international clinical trials and guidelines. Her work extends to writing for Orphanet and consulting with “Best Doctors.” Dr. Massimino continues to shape the future of pediatric oncology through her research, teaching, and compassionate patient care.

Profile

Scopus

Orcid

Scholar

🎓 Education

Dr. Maura Massimino obtained her MD degree in 1987 from the University of Milan. She further specialized in Hematology in 1991 and Pediatrics in 1995, also from the University of Milan. These strong medical foundations equipped her with deep interdisciplinary expertise vital for pediatric oncology. In addition to her formal medical training, she has pursued continued professional development, earning certifications including GCP (2024), PALS (2023), and BLSD (2024), highlighting her commitment to ongoing learning and up-to-date clinical practices. Dr. Massimino’s academic development aligns with her strong engagement in both research and patient-centered pediatric care, especially in complex oncological conditions. She also contributes extensively to medical education, serving as a contract professor at various universities such as the University of Milan-Bicocca and the University of Milan since 2010. Her educational journey reflects a life-long commitment to excellence in clinical, academic, and research domains of pediatric oncology.

💼 Experience

Dr. Massimino began her career in 1987 as a research fellow at Fondazione IRCCS Istituto Nazionale dei Tumori. By 1989, she joined the pediatric oncology staff full-time and, in 2010, rose to become Director of the Pediatric Oncology Unit. She has since led clinical care and research focused on pediatric brain tumors, lymphomas, and thyroid cancers. Her administrative contributions include overseeing hospitalization alignment (DRG) and holding senior leadership in pediatric neuro-oncology since 2006. As a professor, she teaches oncology in multiple Milanese institutions and master’s programs, including psycho-oncology and palliative care. Dr. Massimino also serves as a clinical trial principal investigator in numerous international and phase I–III studies, ensuring access to cutting-edge treatments. Her consultative and organizational expertise extends to national health policy and academic curricula development. Her impact spans healthcare delivery, research leadership, and academic mentorship in pediatric cancer care.

🏅 Awards and Honors

Dr. Massimino has earned widespread recognition in pediatric oncology for her clinical and academic contributions. While specific awards are not listed in the CV, her achievements include leading international clinical trials, publishing over 350 peer-reviewed articles, contributing to more than 400 conference presentations, and authoring major textbook chapters in both Italian and English. She is a featured contributor to Orphanet, a globally respected database for rare diseases and orphan drugs. Since 2000, she has held functional leadership roles and has been recognized with high-ranking administrative titles. Dr. Massimino serves as a trusted expert for “Best Doctors,” a global medical network affiliated with Harvard Medical School, signifying her international standing. Her ongoing teaching appointments at prestigious Milan universities and involvement in national and European research networks underscore her dedication to pediatric oncology and her stature as one of the most respected experts in the field.

🔬 Research Focus

Dr. Massimino’s research focuses on pediatric brain tumors, particularly gliomas, medulloblastomas, and ependymomas, as well as lymphomas and thyroid malignancies in children. She is the principal investigator in numerous phase I/II/III international trials exploring novel therapies, including nimotuzumab, vinorelbine, dabrafenib, trametinib, pomalidomide, and ponatinib. Her work prioritizes translational approaches combining targeted therapy, immunotherapy, and precision medicine. She also investigates long-term survivorship outcomes, addressing late effects in pediatric cancer survivors. Her sub-investigator roles include studies on rituximab, afatinib, durvalumab, tazemetostat, and DAY101. As a researcher, she aims to improve diagnosis, safety, and efficacy in pediatric oncology while integrating pharmacogenomics and neuro-oncological insights. Additionally, Dr. Massimino is actively involved in the European Reference Network on Pediatric Cancer. Her research efforts align closely with clinical innovations, ensuring that scientific discoveries lead to meaningful improvements in patient care and survival in pediatric oncology.

✅ Conclusion

Dr. Maura Rita Maria Massimino stands as a leading figure in pediatric oncology with a remarkable portfolio of clinical research, leadership, and academic mentorship. Her contributions have tangibly shaped treatment protocols for pediatric brain tumors and her work continues to benefit patients globally. Given the quality, originality, and clinical significance of her research output, she is an exceptionally strong candidate for the Best Research Article Award. Her continued engagement in high-impact studies and educational endeavors reinforces her role as a transformative figure in pediatric cancer research.

Publications


1. Title: European standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescence
Year: 2025
Authors: Alba Rubio-San-Simón et al.
Link: https://doi.org/10.1016/j.ejcped.2025.100227


2. Title: European standard clinical practice recommendations for paediatric high-grade gliomas
Year: 2025
Authors: Elwira Szychot et al.
Link: https://doi.org/10.1016/j.ejcped.2024.100210


3. Title: Dabrafenib and Trametinib for the Treatment of Pediatric and Adolescent Melanoma: Single Center Experience Data From Italian Compassionate Use
Year: 2025
Authors: Stefano Chiaravalli et al.
Link: https://doi.org/10.1002/pbc.31644


4. Title: Ho Preso Un Granchio: The Sitcom Created by Young Patients That Turns the Cancer Journey Into Comedy
Year: 2025
Authors: Andrea Ferrari et al.
Link: https://doi.org/10.1002/pbc.31582


5. Title: MicroRNAs Expression Profile in MN1-Altered Astroblastoma
Year: 2025
Authors: Francesca Gianno et al.
Link: https://doi.org/10.3390/biomedicines13010112


6. Title: Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype
Year: 2025
Authors: Maura Massimino et al.
Link: https://doi.org/10.1093/neuonc/noae189


7. Title: Being diagnosed with a rhabdomyosarcoma in the era of artificial intelligence: Whom can we trust?
Year: 2024
Authors: Carlo Alfredo Clerici et al.
Link: https://doi.org/10.1002/pbc.31256

JIE MENG | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. JIE MENG | Neuroscience | Best Researcher Award 🏆

Assistant Professor at Sichuan University, China.

Dr. Jie Meng is an Assistant Professor at Sichuan University, China. With expertise in [specific field, e.g., molecular biology, environmental science, engineering], Dr. Meng has contributed significantly to both research and teaching. His work focuses onDr. Meng has published [number] papers in reputed journals and actively participates in academic conferences. He is committed to advancing knowledge in his field while fostering a collaborative learning environment for students at Sichuan University.

Profile

ORCID

Scopus

Education 🎓:

Jie Meng holds a Ph.D. in Neuroscience from Kyushu University, Japan, completed in 2019. This advanced education provided a solid foundation in understanding the intricate mechanisms underlying neurodegenerative diseases.

Work Experience 💼:

Jie Meng is currently an Intermediate Researcher at Sichuan University West China Hospital in Chengdu, China, a position held since 2019. In this role, Jie Meng conducts cutting-edge research into neurodegenerative diseases, focusing particularly on Alzheimer’s disease and Parkinson’s disease.

Awards and Honors

Jie Meng’s exceptional contributions to the field of neuroscience have been recognized with several awards, including the Qinghai Province Science and Technology Award, where he received the Second Prize in Natural Science for his innovative work in neurodegeneration research.

Research Interests:

Jie Meng’s research primarily revolves around the mechanisms of neurodegenerative diseases, with a strong emphasis on microglia-mediated neuroinflammation in Alzheimer’s disease (AD). His work seeks to identify novel epigenetic biomarkers for early-onset Parkinson’s disease (PD) and explore therapeutic strategies aimed at mitigating chronic neuroinflammation.,Investigating the role of microglia in neuroinflammation and how it contributes to AD progression.,Exploring epigenetic biomarkers that can aid in the early detection of Parkinson’s disease.,Developing innovative therapeutic approaches to target chronic neuroinflammation in neurodegenerative disorders.

📚 Publication 

  • Testing cognitive normal for Alzheimer’s disease prediction
    Citations: 0
    Year: 2025
    Authors: Meng, J., Lei, P.
    Journal: Journal of Neurochemistry

 

  • Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke
    Citations: 2
    Year: 2024
    Authors: Du, B., Deng, Z., Chen, K., Tuo, Q.-Z., Lei, P.
    Journal: Genes and Diseases

 

 

  • How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer’s disease
    Citations: 12
    Year: 2024
    Authors: Ni, J., Xie, Z., Quan, Z., Meng, J., Qing, H.
    Journal: GLIA

 

  • Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway
    Citations: 5
    Year: 2024
    Authors: Xu, S., Tuo, Q.-Z., Meng, J., Li, C.-L., Lei, P.
    Journal: Translational Oncology

 

 

  • Leucine-rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule-associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
    Citations: 3
    Year: 2023
    Authors: Chen, K., Tang, F., Du, B., Lei, P., Wei, X.-W.
    Journal: MedComm

 

  • The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
    Citations: 8
    Year: 2023
    Authors: Xie, Z., Meng, J., Wu, Z., Qing, H., Ni, J.
    Journal: Neuroscientist

 

  • Scopolamine causes delirium-like brain network dysfunction and reversible cognitive impairment without neuronal loss
    Citations: 8
    Year: 2023
    Authors: Wang, Q., Zhang, X., Guo, Y.-J., Yue, J.-R., Lei, P.
    Journal: Zoological Research

 

  • Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer’s disease
    Citations: 14
    Year: 2022
    Authors: Xie, Z., Meng, J., Kong, W., Qing, H., Ni, J.
    Journal: Aging Cell

 

  • Differential Expression and Distinct Roles of Proteinase-Activated Receptor 2 in Microglia and Neurons in Neonatal Mouse Brain After Hypoxia-Ischemic Injury
    Citations: 6
    Year: 2022
    Authors: Liu, Y., Li, H., Hu, J., Qing, H., Ni, J.
    Journal: Molecular Neurobiology

 

  • Nucleus distribution of cathepsin B in senescent microglia promotes brain aging through degradation of sirtuins
    Citations: 28
    Year: 2020
    Authors: Meng, J., Liu, Y., Xie, Z., Lei, P., Ni, J.
    Journal: Neurobiology of Aging

 

Conclusion 

In conclusion, to fully assess Dr. Jie Meng’s suitability for the Best Researcher Award, one would need to gather detailed information on their research outputs, contributions to the field, collaborations, and overall recognition. If their work aligns with the criteria outlined above, Dr. Meng could very well be a strong contender for the award. Additionally, providing more details on their specific research achievements would allow for a more tailored evaluation and clearer recommendations for areas where they could continue to excel.

 

Harender Kumar | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Harender Kumar | Neuroscience | Best Researcher Award 🏆

Research Scholar at Panjab University Chandigarh, India.

Harender Kumar, a Research Scholar at Panjab University, Chandigarh, specializes in behavioral neuroscience. His work primarily focuses on investigating the relationship between diet, gut health, and stress resilience using zebrafish as a model organism. Kumar has published three notable journal articles in SCI/Scopus-indexed journals, with impactful contributions to neuroscience and chemistry. His research demonstrates a promising ability to bridge fundamental science with potential real-world applications.

Profile

Scopus

Education 🎓:

Harender Kumar is pursuing his Ph.D. at Panjab University, Chandigarh, focusing on behavioral neuroscience. His academic journey reflects his dedication to understanding the complex interplay between biological systems and mental health. Harender’s educational background has provided a strong foundation in neuroscience, biology, and chemistry, enabling him to engage in cutting-edge research. At Panjab University, he has honed his expertise in experimental design, data analysis, and interdisciplinary collaboration, contributing significantly to his academic and professional growth. Through his education, Harender has developed a keen interest in the gut-brain axis, stress mechanisms, and the therapeutic potential of dietary interventions, preparing him for a promising career in research and innovation.

Work Experience 💼:

Harender Kumar has significant experience in behavioral neuroscience research, with a focus on gut-brain interactions and stress resilience. As a Research Scholar at Panjab University, he has conducted innovative studies using zebrafish models, exploring how dietary components influence mental health. Harender has collaborated with experts in chemistry to address diverse scientific challenges, such as detecting chemical agents and understanding synaptic remodeling. His hands-on expertise includes experimental planning, animal model studies, and data interpretation, which have resulted in publications in SCI/Scopus-indexed journals. Harender’s multidisciplinary experience reflects his ability to navigate complex scientific questions and contribute meaningfully to neuroscience and beyond.

Awards and Honors

Though specific awards and honors are not mentioned in the profile, Harender Kumar’s accomplishments in publishing high-quality research in reputable journals demonstrate academic recognition. His work has contributed to advancing behavioral neuroscience and interdisciplinary science. Securing awards such as research grants, best paper accolades, or conference presentations would further highlight his achievements and scholarly impact.

Research Interests:

Harender Kumar’s research centers on behavioral neuroscience, with an emphasis on understanding the gut-brain axis and its role in stress resilience. Using zebrafish as a model organism, he investigates the link between dietary factors and mental well-being, providing insights into potential therapeutic strategies. His multidisciplinary work integrates neuroscience, physiology, and chemistry, addressing critical issues such as synaptic remodeling and the stress-resilient effects of dietary interventions. Harender’s innovative approach has contributed to a deeper understanding of mental health challenges and opened avenues for novel dietary strategies to enhance emotional resilience.

📚 Publications 

Stress-resilient Effect of Spirulina platensis on Zebrafish Chronic Unpredictable Stress Model

Authors: Kumar, H., Kaur, K., Kaur, R.

Journal: Physiology & Behavior

Year: 2024

Citations: 0

Role of Spirulina in Structural Remodeling of Synapse in Telencephalon of Chronic Unpredictable Stress Model of Zebrafish

Authors: Kumar, H., Garg, V., Kaur, K., Kaur, R.

Journal: Annals of Neurosciences

Year: 2023

Citations: 0

Synthesis of a Trinuclear Zinc(II) Cluster Composed of [4.4.3.01,5]Tridecane Cages: A Rapid Detection and Degradation Probe for the Chemical Warfare Agent Simulant Diethyl Cyanophosphonate in Protein-rich Food Products

Authors: Thakur, S., Rohilla, J., Kumar, K., Kumar, H., Singh, R., Kaur, V., Kamboj, R.

Journal: Analyst

Year: 2023

Citations: 4

Conclusion 

Harender Kumar exhibits strong potential as a researcher in behavioral neuroscience, with impactful publications and an innovative focus on the gut-brain axis. While his current portfolio demonstrates high-quality research and interdisciplinary collaboration, there is room to enhance his profile by securing funded projects, expanding his professional engagement, and increasing the impact of his work through broader dissemination and applications. Overall, Harender is a commendable candidate for the Best Researcher Award, particularly for early-career recognition.

 

 

Amir Hossein Zarifkar | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Amir Hossein Zarifkar | Neuroscience | Best Researcher Award 🏆

Faculty member at Larestan University of Medical Sciences, Iran.

Dr. Amir Hossein Zarifkar is a dedicated researcher in the field of neurophysiology, specializing in Alzheimer’s disease models, memory impairment, and the effects of transcranial electrical stimulation. He holds a Ph.D. in Physiology, and his expertise includes stereotaxic surgery, cognitive testing, and advanced biochemical and histological techniques. His research contributions are evidenced by peer-reviewed publications, prestigious awards, and active participation in scientific conferences. As a teacher, he has guided students across multiple disciplines in physiology, further demonstrating his commitment to academia.

Profile

Scopus

Google Scholar

Education 🎓:

Dr. Zarifkar’s academic journey began with a B.Sc. in Biology from Shiraz University, Iran (2010), where he laid the foundation for his passion in life sciences. He pursued his M.Sc. in Physiology at Ahvaz University of Medical Sciences (2014), conducting a thesis on the protective effects of agmatine in memory impairment models. Building upon this expertise, Dr. Zarifkar earned a Ph.D. in Physiology from Shiraz University of Medical Sciences (2019). His doctoral research, titled “Investigating the effect of transcranial electrical stimulation (tES) paradigms on beta-amyloid-induced memory impairment and hippocampal CA1 structural changes in male rats,” received critical acclaim for its innovative approach to addressing Alzheimer’s disease. Throughout his education, Dr. Zarifkar consistently ranked among the top of his cohort, achieving first rank in the national Ph.D. entrance exam and being honored as a top student at Shiraz University of Medical Sciences.

Work Experience 💼:

Dr. Zarifkar has over a decade of experience in teaching, research, and experimental neurophysiology. As an educator, he delivers comprehensive courses in nervous system, kidney, gastrointestinal, and endocrine physiology to students in medicine, dentistry, pharmacy, and nursing. His hands-on laboratory sessions emphasize practical applications of physiology, fostering a deeper understanding among students. On the research front, Dr. Zarifkar specializes in Alzheimer’s disease, memory impairment, and innovative therapeutic approaches, utilizing advanced methodologies such as transcranial electrical stimulation, immunohistochemistry, and stereotaxic surgery. His expertise extends to conducting behavioral and cognitive experiments in animal models. Dr. Zarifkar’s findings have been presented at national and international conferences, enhancing the global understanding of neurodegenerative diseases. As a member of Iran’s National Elites Foundation, he actively contributes to academic and research communities, solidifying his role as a leader in the field of neurophysiology.

Awards and Honors 🏆

Dr. Zarifkar has received multiple awards and recognitions for his academic excellence and contributions to neuroscience. Notably, he ranked first in the national Ph.D. entrance exam in Physiology, demonstrating his exceptional knowledge in the field. During his M.Sc. and Ph.D. studies, he was honored as a top student at Shiraz University of Medical Sciences. His groundbreaking research on Alzheimer’s disease earned him accolades at national and international scientific conferences. Dr. Zarifkar is also a proud member of Iran’s National Elites Foundation, a prestigious acknowledgment of his academic and research achievements. His dedication to teaching and mentoring has further earned him the respect and admiration of his peers and students alike. These honors reflect Dr. Zarifkar’s unwavering commitment to advancing the field of physiology and contributing to the understanding and treatment of neurodegenerative disorders.

Research Interests:

Dr. Zarifkar’s research centers on understanding the mechanisms underlying neurodegenerative diseases, particularly Alzheimer’s disease, and developing innovative therapeutic strategies. His Ph.D. work investigated the effects of transcranial electrical stimulation (tES) on memory impairment and structural changes in the hippocampus, providing insights into non-invasive treatments for Alzheimer’s. Dr. Zarifkar’s expertise extends to studying the impact of neuroprotective agents like agmatine on cognitive functions and neural plasticity. He employs advanced methodologies, including behavioral and cognitive assessments in animal models, immunohistochemistry, Western blot analysis, and stereotaxic surgery, to unravel the complexities of memory impairment. His findings contribute to a better understanding of the pathophysiology of neurodegenerative disorders and pave the way for potential clinical applications. By bridging experimental neuroscience with translational research, Dr. Zarifkar aims to develop effective interventions for enhancing cognitive health and mitigating the effects of aging-related neurological conditions.

📚 Publications 

Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis, and Akt/GSK3β signaling disruption

Authors: M. Moosavi, A.H. Zarifkar, Y. Farbood, M. Dianat, A. Sarkaki, R. Ghasemi

Citations: 46

Year: 2014

Treatment with edaravone improves the structure and functional changes in the hippocampus after chronic cerebral hypoperfusion in rats

Authors: G.H. Meftahi, M. Bayat, A.H. Zarifkar, S. Akbari, A.B. Haghighi, M. Naseh

Citations: 18

Year: 2021

Ameliorative effects of different transcranial electrical stimulation paradigms on the novel object recognition task in a rat model of Alzheimer disease

Authors: A.H. Zarifkar, A. Zarifkar, M. Nami, A. Rafati, H. Aligholi, F. Vafaee

Citations: 12

Year: 2019

Effect of recombinant insulin-like growth factor-2 injected into the hippocampus on memory impairment following hippocampal intracerebral hemorrhage in rats

Authors: F. Vafaee, A. Zarifkar, M. Emamghoreishi, M.R. Namavar, M. Shahpari

Citations: 10

Year: 2018

Interactive Effects of Swimming High-Intensity Interval Training and Resveratrol Supplementation Improve Mitochondrial Protein Levels in the Hippocampus of Aged Rats

Authors: M. Amirazodi, F. Daryanoosh, A. Mehrabi, A. Gaeini, M. Koushkie Jahromi

Citations: 6

Year: 2022

The Comparison of the Effects of Different Transcranial Electrical Stimulation (tES) Paradigms on Beta-Amyloid (Aβ 25–35)-Induced Memory Impairment upon Morris Water Maze Task

Authors: A.H. Zarifkar, A. Zarifkar, M. Nami, A. Rafati, H. Aligholi

Citations: 5

Year: 2018

Different paradigms of transcranial electrical stimulation improve motor function impairment and striatum tissue injuries in the collagenase-induced intracerebral hemorrhage model

Authors: A.R. Heidarzadegan, A. Zarifkar, N. Sotoudeh, M.R. Namavar, A.H. Zarifkar

Citations: 4

Year: 2022

The protective effect of agmatine against intracerebroventricular streptozotocin-induced memory impairment in male rats

Authors: Y. Farbood, A.H. Zarifkar, M. Dianat, A. Sarkaki, M. Moosavi

Citations: 1

Year: 2014

Resistance Training and Resveratrol Supplementation Improve Cancer Cachexia and Tumor Volume in Muscle Tissue of Male Mice Bearing Colon Cancer CT26 Cell Tumors

Authors: M. Samadi, F. Daryanoosh, Z. Mojtahedi, A. Samsamy Pour, H. Nobari

Citations: Not yet cited

Year: 2024

Alterations in FoxO3a, NF-κB, and MuRF1 Expression in the Soleus Muscle of Male Rats Following High-Intensity Interval Training and Detraining

Authors: S. Sheibani, F. Daryanoosh, A.H. Zarifkar

Citations: Not yet cited

Year: 2024

Different paradigms of transcranial electrical stimulation induce structural changes in the CA1 region of the hippocampus in a rat model of Alzheimer’s disease

Authors: A.H. Zarifkar, A. Zarifkar, S. Safaei

Citations: Not yet cited

Year: 2024

P62: Agmatine Protects Against Intracerebroventricular Streptozotocin-Induced Water Maze Memory Deficit, Hippocampal Apoptosis and Akt/GSK3β Signaling Disruption

Authors: M. Moosavi, A.H. Zarifkar, Y. Farbood, M. Dianat, A. Sarkaki, R. Ghasemi

Citations: Not listed

Year: 2018

Conclusion 

Dr. Amir Hossein Zarifkar demonstrates an exceptional commitment to advancing neurophysiology research and teaching. His strengths, including rigorous experimental skills, teaching proficiency, and recognized achievements, position him as a strong candidate for a Best Researcher Award. Addressing areas like international visibility, grant acquisition, and translational focus could further strengthen his profile. Overall, his impactful contributions to Alzheimer’s research and academic excellence make him a deserving nominee.

 

 

Niki Vassilaki | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Niki Vassilaki | Neuroscience | Best Researcher Award  🏆

Researcher at Hellenic Pasteur Institute, Greece

Dr. Niki Vassilaki is a leading expert in Molecular Virology, specializing in the replication of Hepatitis C Virus (HCV) and viral infections such as those caused by Flaviviridae and SARS-CoV-2. She holds a PhD in Molecular Virology from the National and Kapodistrian University of Athens (NKUA) and completed postdoctoral research at Heidelberg University with Professor Ralf Bartenschlager. Dr. Vassilaki’s research focuses on the role of dopamine metabolism in viral infections and the development of antiviral drugs. With over 60 publications and more than 110 conference presentations, she has secured over €1 million in competitive funding and is a key partner in the European EXPAND-EV program.

Profile

Scopus

Google Scholar

ORCID

Education 🎓:

Dr. Niki Vassilaki completed her PhD in Molecular Virology at the Biology Department of the National and Kapodistrian University of Athens (NKUA), where she focused on Hepatitis C Virus (HCV) replication. Her doctoral research laid the foundation for her deep expertise in viral pathogenesis. She further expanded her knowledge and research capabilities during her postdoctoral studies at Heidelberg University, working in the world-renowned virology laboratory of Professor Ralf Bartenschlager. This experience allowed her to contribute to the development of robust infectious models for studying HCV replication, solidifying her reputation in the virology research community.

Work Experience 💼:

Dr. Niki Vassilaki has extensive experience in molecular virology, focusing on viral replication and pathogenesis. She pursued her PhD at the National and Kapodistrian University of Athens (NKUA) under the mentorship of Professor Mavromara, where she specialized in Hepatitis C Virus (HCV) replication. Following this, Dr. Vassilaki conducted postdoctoral research at Heidelberg University with Professor Ralf Bartenschlager, contributing to the development of a robust infectious model for HCV. Her current research explores the role of dopamine biosynthesis and metabolism in viral infections, particularly Flaviviridae and SARS-CoV-2, with an emphasis on antiviral drug discovery. She has also held leadership roles, including coordinator of multiple international research programs and membership in various virology and molecular biology committees.

Skills 🔍

Dr. Niki Vassilaki possesses a broad range of skills in molecular virology, viral pathogenesis, and antiviral drug discovery. She has expertise in the molecular biology of Flaviviridae, Hepadnavirus (HBV), and SARS-CoV-2, with a strong focus on viral replication mechanisms and the identification of novel therapeutic targets. Dr. Vassilaki is skilled in advanced laboratory techniques, including PCR, RNA sequencing, and virus culture systems, as well as in designing and executing antiviral assays. Additionally, she has extensive experience in securing competitive funding, managing international research collaborations, and leading research teams focused on innovative antiviral solutions.

Research Interests:

Dr. Niki Vassilaki’s research interests lie at the intersection of molecular virology, viral pathogenesis, and antiviral drug discovery. Her work primarily focuses on the replication mechanisms of Flaviviridae viruses, Hepatitis B virus (HBV), and SARS-CoV-2. She is particularly interested in understanding the molecular interactions that govern viral replication and the development of novel replication inhibitors. Additionally, her research explores the role of dopamine biosynthesis and metabolism in viral infections, aiming to uncover how these pathways influence viral pathogenesis. Dr. Vassilaki is also dedicated to the discovery of antiviral agents, with her team developing an ISO-certified pipeline for screening and testing potential therapeutics.

📚 Publications 

  • Title: Alternate translation occurs within the core coding region of the hepatitis C viral genome
    • Authors: A Varaklioti, N Vassilaki, U Georgopoulou, P Mavromara
    • Journal: Journal of Biological Chemistry
    • Volume: 277, Issue 20, Pages: 17713-17721
    • Cited by: 238
    • Year: 2002
  • Title: Role of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and Replication
    • Authors: N Vassilaki, P Friebe, P Meuleman, S Kallis, A Kaul, G Paranhos-Baccala, …
    • Journal: Journal of Virology
    • Volume: 82, Issue 23, Pages: 11503-11515
    • Cited by: 130
    • Year: 2008
  • Title: Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/core+1 coding open reading frame
    • Authors: N Vassilaki, P Mavromara
    • Journal: Journal of Biological Chemistry
    • Volume: 278, Issue 42, Pages: 40503-40513
    • Cited by: 122
    • Year: 2003
  • Title: The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product
    • Authors: N Vassilaki, P Mavromara
    • Journal: IUBMB Life
    • Volume: 61, Issue 7, Pages: 739-752
    • Cited by: 91
    • Year: 2009
  • Title: Low oxygen tension enhances hepatitis C virus replication
    • Authors: N Vassilaki, KI Kalliampakou, I Kotta-Loizou, C Befani, P Liakos, G Simos, …
    • Journal: Journal of Virology
    • Volume: 87, Issue 5, Pages: 2935-2948
    • Cited by: 65
    • Year: 2013
  • Title: Impact of age and sex on antibody response following the second dose of COVID-19 BNT162b2 mRNA vaccine in Greek healthcare workers
    • Authors: N Vassilaki, AN Gargalionis, A Bletsa, N Papamichalopoulos, E Kontou, …
    • Journal: Microorganisms
    • Volume: 9, Issue 8, Article: 1725
    • Cited by: 60*
    • Year: 2021

Conclusion 

Dr. Niki Vassilaki’s academic credentials, groundbreaking research, leadership in international committees, and professional affiliations make her a highly deserving candidate for the Research for Best Researcher Award. Her contributions to molecular virology, antiviral discovery, and global scientific collaborations highlight her excellence and dedication to advancing the field.

Yuandong Gu | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Yuandong Gu | Neuroscience | Best Researcher Award   🏆

Vice President at National Innovation Center par Excellence, China

Prof. Dr. Yuandong Gu is a distinguished researcher and innovator in microelectronics and sensor technology. He serves as the Vice Dean of the Shanghai Yangtze Delta Innovation Institute and was the Founding Dean of the School of Microelectronics at Shanghai University. With a PhD from the University of Minnesota, Twin Cities (2003), his research focuses on piezoelectric MEMS sensors, photonic metamaterials, and their transformative applications. Prof. Gu has held key leadership roles, including Deputy Executive Director at Singapore’s Institute of Microelectronics and Principal Scientist at Honeywell International Inc. He is the author of over 180 peer-reviewed publications and holds 55 USA/SGP patents. His groundbreaking work has earned him prestigious accolades, such as the Shanghai Talent Program Award (2018) and the Engineering Achievement Award from the Institution of Engineers Singapore.

Profile

Scopus

Education 🎓:

Prof. Dr. Yuandong Gu earned his PhD in 2003 from the University of Minnesota, Twin Cities, specializing in advanced sensor technologies and microelectronics. His doctoral work laid the foundation for his illustrious career in piezoelectric MEMS sensors and photonic metamaterials, fields where he has made groundbreaking contributions. His strong academic background is complemented by his ability to bridge theoretical research with industrial applications, making him a leader in innovative technology development.

Work Experience 💼:

Prof. Dr. Yuandong Gu has extensive experience in academia, research, and industry, serving as the Vice President of the Shanghai Yangtze Delta Innovation Institute and Chairman of Shanghai Melon Technology Co., Ltd. He was the Founding Dean of the School of Microelectronics at Shanghai University and a Senior Vice President at SITRI, driving technology commercialization and innovation strategies. At A-STAR Singapore, he led advanced MEMS research as Deputy Executive Director, and at Honeywell International, he managed multi-million-dollar MEMS projects and established the Shanghai Sensors Lab, showcasing his global leadership in microelectronics and sensor technologies.

Skills 🔍

Prof. Dr. Yuandong Gu is a highly skilled researcher and leader with expertise in microelectronics, piezoelectric MEMS technologies, and photonic metamaterials. He excels in strategic planning, technology incubation, and the development of cutting-edge sensor platforms, including pMUTs and MEMS-based force sensing modules. His proficiency in project management, cross-functional team leadership, and research-to-market transformation has been demonstrated through his successful execution of multimillion-dollar projects and the commercialization of innovative technologies. With a strong foundation in intellectual property generation, holding 55 patents, and an extensive publication record, he combines technical expertise with visionary leadership to drive impactful advancements in the field.

Research Interests:

Prof. Dr. Yuandong Gu’s research interests encompass cutting-edge advancements in piezoelectric MEMS sensors, photonic metamaterials, and their diverse applications. His work focuses on developing innovative sensing technologies, such as piezoelectric micromachined ultrasonic transducers (pMUTs), and exploring the integration of photonic metamaterials to enhance device performance in various fields. These research efforts aim to address challenges in miniaturization, high precision, and energy efficiency, contributing to advancements in areas such as healthcare, robotics, and communication systems. His dedication to translating research into impactful technologies underscores his contributions to the global microelectronics and sensors community.

📚 Publications 

A 16-channel Si Probe Monolithically Integrated with CMOS Chips for Neural Recording

  • Authors: Gou, G.-Y., You, C., Yao, P., Xue, N., Zhao, M.
  • Journal: Sensors and Actuators Reports
  • Publication Year: 2024
  • Volume: 8
  • Article Number: 100206
  • Open Access

Improved Performance of Acoustically Actuated Magnetoelectric Antenna with FeGa/FeGaB Bilayer

  • Authors: Li, K., Zhang, Q., Chang, Y., Zhang, S., Gu, Y.
  • Journal: Micromachines
  • Publication Year: 2024
  • Volume: 15
  • Issue: 2
  • Article Number: 190
  • Open Access

Effect of Humid Environment on Electromechanical Performance of Piezoelectric Micromachined Ultrasonic Transducers (PMUTs)

  • Authors: Tong, Z., Wu, Z., Gu, Y.A., Lou, L.
  • Journal: Sensors and Actuators A: Physical
  • Publication Year: 2024
  • Volume: 366
  • Article Number: 114821

MHorUNet: High-Order Spatial Interaction UNet for Skin Lesion Segmentation

  • Authors: Wu, R., Liang, P., Huang, X., Zhu, H., Chang, Q.
  • Journal: Biomedical Signal Processing and Control
  • Publication Year: 2024
  • Volume: 88
  • Article Number: 105517
  • Citations: 13

Enhancement in Performance of SAW Resonator on LN/SiC Substrate by Taking Slowness Asymmetry into Account

  • Authors: Liu, H.L., Zhang, Q.Z., Sun, H., Gu, Y.D., Wang, N.
  • Journal: Journal of Physics: Conference Series
  • Publication Year: 2024
  • Volume: 2822
  • Issue: 1
  • Article Number: 012174

A Miniaturized Transit-Time Ultrasonic Flowmeter Based on ScAlN Piezoelectric Micromachined Ultrasonic Transducers for Small-Diameter Applications

  • Authors: Gao, Y., Chen, M., Wu, Z., Gu, Y.A., Lou, L.
  • Journal: Microsystems and Nanoengineering
  • Publication Year: 2023
  • Volume: 9
  • Issue: 1
  • Article Number: 49
  • Citations: 15

A Highly Integrated 3D MEMS Force Sensing Module With Variable Sensitivity for Robotic-Assisted Minimally Invasive Surgery

  • Authors: Hou, C., Wang, K., Wang, F., Chen, T., Sun, L.
  • Journal: Advanced Functional Materials
  • Publication Year: 2023
  • Volume: 33
  • Issue: 43
  • Article Number: 2302812
  • Citations: 12

Conclusion 

Prof. Dr. Yuandong Gu’s extensive contributions to advanced sensor technology, impactful industrial innovations, and dedication to academic mentorship make him a strong candidate for the Research for Best Researcher Award. His balance of academic rigor, innovation, and leadership perfectly aligns with the award’s criteria, reflecting his global stature as a transformative researcher.

 

Raziel Arias | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Raziel Arias | Neuroscience | Best Researcher Award

Investigador Asociado at Universidad Michoacana de San Nicolas de Hidalgo. Facultad de Ciencias Médicas y Biológicas “Dr. Ignacio Chávez”, Mexico🎓

Raziel Alejandro Arias Sánchez is a highly accomplished researcher with expertise in biotechnology and health sciences, particularly in clinical and experimental pathophysiology. His work focuses on chronic degenerative diseases, including neurodegeneration and diabetes mellitus.  He has earned academic distinctions and contributed to impactful scientific literature as the primary author of articles and book chapters in reputable journals like Molecules. Raziel has actively participated in conferences, presented research, and contributed to the scientific community through collaborative projects and dissemination activities.

 

Profile 

Education 🎓:

Dr. Arias holds a Ph.D. and M.A./M.Phil. in Socio-Medical Sciences from Columbia University. Her undergraduate studies were completed at the Autonomous University of the State of Morelos (UAEM), where she earned a Licenciatura in Social Anthropology. Her academic training integrates anthropological insights with a focus on public health issues such as gender, migration, and health access. This foundation has supported her innovative research on cross-border health issues and community-based participatory methodologies.

Work Experience 💼:

Dr. Arias has extensive experience in both academic and fieldwork settings. She has been an adjunct and full-time faculty member at institutions like Augsburg University, designing and teaching hybrid courses. Her earlier work involved qualitative research on U.S.-Mexico migration, gender, and health. Notably, she participated in the Feeding the Family in Troubled Times study in Mexico, which analyzed household consumption and nutrition patterns. Additionally, she engaged with Latino communities in New York, focusing on barriers to healthcare and cultural adaptations

Awards and Honors🏆

Dr. Arias has received recognition for her interdisciplinary work linking cultural anthropology and socio-medical sciences. Although specific awards were not listed in the data reviewed, her academic contributions and innovative teaching approaches have positioned her as a leader in cross-disciplinary research. Institutions such as Columbia University and Augsburg University have supported her impactful work, reflecting the academic value she brings to these fields

Research Focus 🔬:

Dr. Arias’s research centers on the interplay between migration, health, and identity. Her work explores how transnational experiences shape health outcomes, focusing on unaccompanied youth and marginalized Latino communities. Key themes include gender dynamics, cultural identity, access to reproductive healthcare, and the effects of mobility on chronic illnesses like HIV. She emphasizes community-based participatory methods to inform culturally sensitive policies and practices

📚 Publications

  • “Polyphenols and Neurodegenerative Diseases: Potential Effects and Mechanisms of Neuroprotection”
  • “Deterioro cognitivo y pérdida neuronal en el giro dentado de ratas adultas con diabetes mellitus tipo II”
      • Year: 2023
      • Source: Presented at the 17º Congreso Estatal de Ciencia, Tecnología e Innovación (Mexico)
  • “Neuroprotective effects of polyphenols in neurodegenerative diseases”
    • Year: 2023
    • Source: Encyclopedia Entry
  • “Investigaciones y Desarrollos Tecnológicos en México 2023”
    • Year: 2023
    • Source: Book Chapter from Investigaciones y Desarrollos Tecnológicos en México 2023

 

Conclusion 

Raziel Alejandro Arias Sánchez demonstrates exceptional promise as a young researcher with a robust foundation in biotechnology and health sciences. His significant contributions to understanding neurodegenerative diseases and chronic illnesses make him a strong candidate for the Best Researcher Award. While he could benefit from broader collaborations and practical applications of his work, his achievements, academic excellence, and dedication to scientific progress set him apart as a deserving recipient of this recognition.

 

 

Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award 🏆

Professor of Pharmacology at Medical School, University of Crete,Greece🎓

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimer’s and spinal cord injury.

 

Professional Profile 

Education 🎓:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience 💼:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills 🔍

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimer’s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors 🏆

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

🤝 Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience 👩‍🏫:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus 🔬:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinson’s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
Conclusion 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

📚 Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Prof. LindaChao | cognitive neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. LindaChao | cognitive neuroscience | Best Researcher Award 🏆

Professor/Research Career Scientist at UCSF/San Francisco VA Health Care System🎓

Dr. Linda L. Chao is a highly respected neuroscientist whose journey began with a B.S. in Biological Sciences and a Ph.D. in Neuroscience from UC Davis. Following her postdoctoral training as a Cognitive Neuroscience Fellow at the National Institute of Mental Health, Dr. Chao joined UCSF, where she is now a Professor in Radiology, Psychiatry, and Behavioral Sciences. She also contributes significantly to veteran health research at the San Francisco VA Medical Center. Renowned for her expertise in cognitive neuroscience and neuroimaging, Dr. Chao employs advanced MRI, PET, and fMRI techniques to study neurodegenerative diseases, Gulf War Illness, and PTSD. Her groundbreaking work in non-pharmacological therapies for Alzheimer’s and trauma-related conditions has earned her prestigious awards, including the UC Davis Graduate Research Award and the NIMH Fellows Award for Research Excellence. As an active member of key neuroscience organizations and a dedicated mentor, Dr. Chao is a vital figure in advancing mental health research and neuroimaging innovations.

Professional Profile 

Education 🎓:

Dr. Linda L. Chao earned her B.S. in Biological Sciences (1987-1991) and a Ph.D. in Neuroscience (1991-1996) from the University of California, Davis. Her dedication to understanding the brain and its functions began here, paving the way for her groundbreaking work in neuroscience and cognitive research.

 

Work Experience 💼:

Dr. Chao’s career reflects a strong commitment to advancing mental health research. Her postdoctoral training took place at the National Institute of Mental Health (NIMH) as a Cognitive Neuroscience Fellow (1996-2000). She joined the University of California, San Francisco (UCSF) as an Assistant Professor in Radiology and Psychiatry in 2001, advancing to Associate Professor and later Professor in the departments of Radiology & Biomedical Imaging, Psychiatry, and Behavioral Sciences. She also holds a significant role with the San Francisco VA Medical Center, where she contributes to research safety and promotes veteran health.

 

Skills 🔍

Dr. Chao is highly skilled in cognitive neuroscience, neuroimaging, and radiology. She has expertise in analyzing brain health through MRI, PET, and fMRI imaging techniques. Her experience extends to research safety, clinical trials, and therapeutic interventions for neurodegenerative diseases and Gulf War Illness. Her innovative skills in cognitive and neuroimaging research support her work in developing non-pharmacological interventions for conditions like PTSD and Alzheimer’s.

 

Awards and Honors 🏆

Dr. Chao’s research excellence is recognized with numerous awards, including the University of California, Davis Graduate Research Award (1994) and the Fellows Award for Research Excellence from the National Institute of Mental Health (1999). These honors underscore her significant contributions to cognitive neuroscience and clinical research.

 

🤝 Memberships:

Dr. Chao is actively involved in multiple professional organizations, including the Society for Neuroscience (SFN), Cognitive Neuroscience Society (CNS), and the International Society to Advance Alzheimer’s Research and Treatment (ISAART). Her memberships reflect her dedication to staying at the forefront of neuroscience, cognitive health, and clinical research.

Teaching Experience 👩‍🏫:

With a passion for mentoring, Dr. Chao has taught at UCSF’s School of Medicine, facilitating courses on brain, mind, and behavior. She has lectured on clinical fMRI applications and led seminars on neuroimaging. Her role as a mentor has influenced many students and researchers in radiology, psychology, and psychiatry, shaping the future of neuroscience.

 

Research Focus 🔬:

Dr. Chao’s research primarily explores cognitive function, neurodegenerative diseases, and neuroimaging in veterans. Her work on Gulf War Illness and the effects of sarin exposure highlights her commitment to understanding trauma impacts on the brain. Additionally, she investigates photobiomodulation therapies, non-pharmacological dementia treatments, and PTSD interventions. Her recent studies reveal the complex interactions between genetic factors and environmental exposures affecting brain health.

Conclusion 

Dr. Linda L. Chao is a deserving candidate for the Best Researcher Award. Her remarkable contributions to cognitive neuroscience, dedication to mentoring, and commitment to understanding the brain’s response to trauma and neurotoxic exposure make her a vital asset to the field. With her current momentum and slight expansion in her research’s reach and collaboration, Dr. Chao is well-positioned to continue making substantial, globally impactful advancements in neuroscience.

📚 Publilcation 

  • Topic: Implementing a new multidisciplinary, remote, dementia staff training program for Veterans Affairs nursing homes
    • Year: 2024
    • Journal: BMC Health Services Research
  • Topic: Olfactory and cognitive decrements in 1991 Gulf War veterans with Gulf War illness/chronic multisymptom illness
    • Year: 2024
    • Journal: Environmental Health: A Global Access Science Source
  • Topic: Current health status of Gulf War deployed and Gulf War era veterans who use Veterans Affairs health care
    • Year: 2024
    • Journal: Journal of Women’s Health
  • Topic: PON1 status in relation to Gulf War Illness: Evidence of gene–exposure interactions from a multisite case–control study of 1990–1991 Gulf War veterans
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Gulf War illness is associated with host gut microbiome dysbiosis and is linked to altered species abundance in veterans from the BBRAIN cohort
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Topic: Livestream, group movement program for people living with cognitive impairment and care partners: A randomized clinical trial
    • Year: 2024
    • Journal: Alzheimer’s and Dementia: Translational Research and Clinical Interventions
  • Topic: Characterizing 1991 Gulf War women veterans from the Boston Biorepository and Integrative Network for Gulf War Illness: Demographics, exposures, neuroimaging, and cognitive outcomes
    • Year: 2024
    • Journal: Clinical Neuropsychologist
  • Topic: Cognitive decrements in 1991 Gulf War veterans: Associations with Gulf War illness and neurotoxicant exposures in the Boston Biorepository, Recruitment, and Integrative Network (BBRAIN) cohorts
    • Year: 2023
    • Journal: Environmental Health: A Global Access Science Source